ES446075A1 - Un procedimiento para la preparacion de unidades de dosifi- cacion oral con liberacion prolongada del componente terape-uticamente activo. - Google Patents

Un procedimiento para la preparacion de unidades de dosifi- cacion oral con liberacion prolongada del componente terape-uticamente activo.

Info

Publication number
ES446075A1
ES446075A1 ES446075A ES446075A ES446075A1 ES 446075 A1 ES446075 A1 ES 446075A1 ES 446075 A ES446075 A ES 446075A ES 446075 A ES446075 A ES 446075A ES 446075 A1 ES446075 A1 ES 446075A1
Authority
ES
Spain
Prior art keywords
procedure
preparation
active component
oral dosage
therapeutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES446075A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of ES446075A1 publication Critical patent/ES446075A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES446075A 1975-03-17 1976-03-16 Un procedimiento para la preparacion de unidades de dosifi- cacion oral con liberacion prolongada del componente terape-uticamente activo. Expired ES446075A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (1)

Publication Number Publication Date
ES446075A1 true ES446075A1 (es) 1977-09-16

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
ES446075A Expired ES446075A1 (es) 1975-03-17 1976-03-16 Un procedimiento para la preparacion de unidades de dosifi- cacion oral con liberacion prolongada del componente terape-uticamente activo.

Country Status (21)

Country Link
JP (1) JPS51115910A (en:Method)
AR (1) AR222624A1 (en:Method)
AT (1) AT353415B (en:Method)
AU (1) AU505355B2 (en:Method)
CA (1) CA1073358A (en:Method)
CH (1) CH630257A5 (en:Method)
DD (1) DD124102A5 (en:Method)
DE (1) DE2611041A1 (en:Method)
DK (1) DK148344C (en:Method)
ES (1) ES446075A1 (en:Method)
FR (1) FR2304354A1 (en:Method)
GB (1) GB1546448A (en:Method)
GR (1) GR60341B (en:Method)
IE (1) IE43083B1 (en:Method)
LU (1) LU74558A1 (en:Method)
MC (1) MC1101A1 (en:Method)
NL (1) NL190313C (en:Method)
NZ (1) NZ180321A (en:Method)
PH (1) PH14927A (en:Method)
PT (1) PT64907B (en:Method)
SE (1) SE433804B (en:Method)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
DE69207656T2 (de) * 1991-01-30 1996-10-17 The Wellcome Foundation Ltd., London Wasserlösliche tabletten
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
US5498422A (en) * 1991-04-08 1996-03-12 Nippon Shinyaku Company Limited Sustained release capsule
DE69322077T2 (de) * 1992-03-25 1999-04-08 Depomed, Inc., Foster City, Calif. Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
WO1995011668A1 (en) * 1993-10-29 1995-05-04 Reckitt & Colman Products Limited Gelatin capsule fill able to foam
EP0725625B1 (en) * 1993-10-29 2000-03-22 R.P. Scherer Corporation Gelatin capsule fill able to foam
WO1995031186A1 (en) * 1994-05-13 1995-11-23 Smithkline Beecham Corporation Method and composition for increasing calcium uptake
CN1172429A (zh) * 1994-12-01 1998-02-04 希博斯药物公司 使用从高等植物中可得到的粉末状水解胶体树胶的持续释放药物运送体系
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (en:Method) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
NL190313C (nl) 1994-01-17
IE43083B1 (en) 1980-12-17
IE43083L (en) 1976-09-17
GR60341B (en) 1978-05-17
GB1546448A (en) 1979-05-23
NL7602776A (nl) 1976-09-21
FR2304354B1 (en:Method) 1979-04-27
NL190313B (nl) 1993-08-16
FR2304354A1 (fr) 1976-10-15
DE2611041A1 (de) 1976-10-14
JPS51115910A (en) 1976-10-13
DE2611041C2 (en:Method) 1988-06-09
PT64907A (fr) 1976-04-01
MC1101A1 (fr) 1977-02-04
AR222624A1 (es) 1981-06-15
PH14927A (en) 1982-01-29
DK113676A (da) 1976-09-18
PT64907B (fr) 1978-03-24
DK148344C (da) 1985-11-04
JPS638084B2 (en:Method) 1988-02-19
SE7603325L (sv) 1976-09-18
LU74558A1 (en:Method) 1977-09-27
CA1073358A (en) 1980-03-11
ATA192276A (de) 1979-04-15
SE433804B (sv) 1984-06-18
NZ180321A (en) 1978-06-20
DD124102A5 (en:Method) 1977-02-02
AT353415B (de) 1979-11-12
CH630257A5 (en) 1982-06-15
DK148344B (da) 1985-06-17
AU1204976A (en) 1977-09-22
AU505355B2 (en) 1979-11-15

Similar Documents

Publication Publication Date Title
ES446075A1 (es) Un procedimiento para la preparacion de unidades de dosifi- cacion oral con liberacion prolongada del componente terape-uticamente activo.
ES8200558A1 (es) Procedimiento para producir un preparado farmaceutico en forma de una pelicula de poliacrilato, adecuado para aplicacionpor via transdermal.
SE8303531D0 (sv) Farmaceutisk komposition
NO178095C (no) Fremgangsmåte for fremstilling av et omhyllet farmasöytisk retarderingspreparat
ES424533A1 (es) Metodo de prolongar la disponibilidad de sustancias farmaco-logicamente activas incluidas en composiciones farmaceuticasa base de alcohol alifatico e hidroxialcohilcelulosa.
DE3271829D1 (en) An allergen dry powder composition and process for its preparation
EP0350701A3 (en) Pharmaceutical cmpositions for oral administration having analgesic and anti-inflammatory activity, possessing excellent palatability and being free of irritating effects on mucous membranes
AR013506A1 (es) Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida
ES2061094T3 (es) Un procedimiento para la obtencion de una formulacion para disminuir el deseo imperioso de alcohol (craving) en el tratamiento del alcoholismo cronico.
AR031682A1 (es) Composiciones farmaceuticas
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
SE8001599L (sv) Transdermalt medicineringssystem for isosorbiddinitrat
KR910005858A (ko) 지방산 요법
JPS5218813A (en) Plasters for the relief of cutaneous diseases
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
ES8400028A1 (es) Metodo de preparacion de una composicion tixotropica anhidra.
ES2078838A1 (es) Procedimiento para preparar una composicion a base de clozapina.
DK78487A (da) Farmaceutisk praeparat indeholdende et i vand kvaeldende polymermateriale
Axelsen et al. Papillary necrosis in the Gunn rat: Rapid induction by analgesics
DE3266072D1 (en) Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
JPS554397A (en) Novel n11benzoylln22phenyll1*33diaminopropane 22ol*its manufacture and medicine containing it for therapy of acute and chronic gastritis
DK0483320T3 (da) Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
GB976096A (en) Pharmaceutical compositions
JPS56169623A (en) Anti-inflammatory and pain-killing spreading plaster
MX9303582A (es) Una forma de unidad de dosis farmaceutica del tipo de capsulas de gelatina suave que contiene clonixinato de lisina y un procedimiento para su preparacion.